Showing 6301-6310 of 10618 results for "".
- Pre- and Postsurgical Opdivo Does Not Boost Relapse-Free Survival in Kidney Cancerhttps://reachmd.com/news/pre-and-postsurgical-opdivo-does-not-boost-relapse-free-survival-in-kidney-cancer/2467590/The recurrence-free survival was 33% in the Opdivo group and surgery-only group in certain patients with kidney cancer. Adding Opdivo (nivolumab) before and after surgery did not improve recurrence-free survival (RFS; the time patients
- Sodium Channels in Breast Cancer Cells a Promising Target for Future Treatments, Study Revealshttps://reachmd.com/news/sodium-channels-in-breast-cancer-cells-a-promising-target-for-future-treatments-study-reveals/2467549/Sodium channels in breast cancer cells a promising target for future treatments, study reveals Posted on 25 July 2024 A new study on live tissue cells is the first to reveal how channels that allow sodium to enter into breast cancer cells enable tumours to grow and
- Pretreatment CT-Based Machine Learning Radiomics Model Predicts Response in Unresectable Hepatocellular Carcinoma Treated with Lenvatinib Plus PD-1 Inhibitors and Interventional Therapyhttps://reachmd.com/news/pretreatment-ct-based-machine-learning-radiomics-model-predicts-response-in-unresectable-hepatocellular-carcinoma-treated-with-lenvatinib-plus-pd-1-inhibitors-and-interventional-therapy/2467541/Background: Lenvatinib plus PD-1 inhibitors and interventional (LPI) therapy have demonstrated promising treatment effects in unresectable hepatocellular carcinoma (HCC). However,
- How Does a Common Skin Bacterium Cause Chronic Infections After Orthopedic Surgeries?https://reachmd.com/news/how-does-a-common-skin-bacterium-cause-chronic-infections-after-orthopedic-surgeries/2467504/In individuals who have undergone knee or hip replacement surgery, clinicians are noticing increasing numbers of chronic bone infections linked to a bacterial strain commonly found on the skin. A new study published in the
- Short Bursts of Light Activity Can Lead to Better Sleep, Study Findshttps://reachmd.com/news/short-bursts-of-light-activity-can-lead-to-better-sleep-study-finds/2467441/Rigorous exercise before bed has long been discouraged, but University of Otago researchers have found short bursts of light activity can lead to better sleep. In a world first study, published in BMJ Open Sport & Exercise Medici
- Common BP Drug May Make Leukemia More Responsive to Chemotherapy While Protecting Hearthttps://reachmd.com/news/common-bp-drug-may-make-leukemia-more-responsive-to-chemotherapy-while-protecting-heart/2467398/Researchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive to chemotherapy, while also protecting the heart against toxicity often caused by cancer treatments.Acute myeloi
- Effectiveness of Valvular Surgery Based on Frailty Risk in Patients with Infective Endocarditishttps://reachmd.com/news/effectiveness-of-valvular-surgery-based-on-frailty-risk-in-patients-with-infective-endocarditis/2467403/The following is a summary of “Impact of valvular surgery according to frailty risk in patients with infective endocarditis,” published in the May 2024 issue of Cardiology by Diaz-Arocutipa et al. Valvular surgery might lo
- People with Long COVID Three Times More Likely to Leave Work - Study - University of Birminghamhttps://reachmd.com/news/people-with-long-covid-three-times-more-likely-to-leave-work-study-university-of-birmingham/2467365/People with Long COVID three times more likely to leave work - studyA study of more than 9,000 people has found that people with Long COVID are at three times higher risk of leaving employment.Published yesterday•
- England's NICE Recommends Lebrikizumab for Moderate-to-Severe ADhttps://reachmd.com/news/englands-nice-recommends-lebrikizumab-moderate-severe-ad/2467289/England’s National Institute for Health and Care Excellence (NICE) has recommended lebrikizumab for use in treating moderate-to-severe atopic dermatitis, Almirall S.A. announced in a press release. Lebrikizumab, sold by Almirall under the brand name Ebglyss, is indicated for the treatment
- Declining Iron Levels in Women in Militaryhttps://reachmd.com/news/declining-iron-levels-in-women-in-military/2467286/After five months of basic military training, the proportion of female recruits with iron deficiency had more than doubled, from 25% to 55%. According to the researchers, this study calls for increased attention and action to improve iron levels.The study, published in the